LGT Financial Advisors »

Cytokinetics shares owned by LGT Financial Advisors

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by LGT Financial Advisors from 13F filings

Historical chart of LGT Financial Advisors investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by LGT Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by LGT Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $41k 583 70.11
2023-12-31 $49k 583 83.49
2023-09-30 $17k 583 29.46